NIE ELISA results. by Jannet A. Tobon Ramos (20855642)

“…<div><p>Background</p><p>Persons with lymphatic filariasis (LF) are often co-infected with soil-transmitted helminths. A single co-administered dose of ivermectin/diethylcarbamazine/albendazole (IDA) is recommended by WHO for mass drug administration (MDA) for LF instead of diethylcarbamazine/albendazole (DA) in Papua New Guinea (PNG). …”

Kato Katz and PCR database 12 months collection. by Jannet A. Tobon Ramos (20855642)

“…<div><p>Background</p><p>Persons with lymphatic filariasis (LF) are often co-infected with soil-transmitted helminths. A single co-administered dose of ivermectin/diethylcarbamazine/albendazole (IDA) is recommended by WHO for mass drug administration (MDA) for LF instead of diethylcarbamazine/albendazole (DA) in Papua New Guinea (PNG). …”

Master database baseline, 4 weeks and 1 year. by Jannet A. Tobon Ramos (20855642)

“…<div><p>Background</p><p>Persons with lymphatic filariasis (LF) are often co-infected with soil-transmitted helminths. A single co-administered dose of ivermectin/diethylcarbamazine/albendazole (IDA) is recommended by WHO for mass drug administration (MDA) for LF instead of diethylcarbamazine/albendazole (DA) in Papua New Guinea (PNG). …”

CaCl₂ and MnCl₂ treatment significantly reduced Pol I occupancy on the rDNA template. by Abigail K. Huffines (20721555)

“…If the <i>p</i>-value < 0.05, that was deemed a significant difference between the two treatment groups and was indicated with either a green (increased occupancy) or black (decreased occupancy) line below the histogram for the CaCl₂ treated samples with respect to the untreated samples. …”

Age-standardized prevalence rates of gynecological diseases across 21 GBD regions, by SDI, from 1990 to 2021. by Xiaofeng He (2618752)

Subjects:

Additional questions on vaccination. by Sara Saleh (6733619)

Subjects:

The raw data file. by Sara Saleh (6733619)

Subjects:

Age-standardized prevalence rates of gynecological diseases across 204 countries and territories in 2021. by Xiaofeng He (2618752)

Subjects:

Estimated annual percentage change in age-standardized prevalence rates of gynecological diseases across 204 countries and territories in 2021. by Xiaofeng He (2618752)

Subjects:

Estimated annual percentage changes in the prevalence rate of specific gynecological diseases from 1990 to 2021, categorized by age group and SDI. by Xiaofeng He (2618752)

Subjects:

Prevalence and trends of gynecological diseases (GDs) among women of childbearing age, by age group and SDI. by Xiaofeng He (2618752)

Subjects:

Prevalence of gynecological diseases (GDs) among women of childbearing age in 2021, along with their changes from 1990 to 2021, and the contribution of each GD to the overall preva... by Xiaofeng He (2618752)

Subjects:

Descriptive characteristics of the sample. by Ronna Bañada (19233063)

Subjects:

Thioflavin-T (ThT) fluorescence analysis of amyloid fibril formation in wild-type and p.R163C mutant αB-crystallin under thermochemical stress. by Aref Baharvand (21713886)

RBM-26 binds to the <i>mals-1</i> mRNA and negatively regulates its expression. by Tamjid A. Chowdhury (14149846)

Regression models of COVID-19-related racial discrimination and depression symptoms among the full sample. by Ronna Bañada (19233063)

Subjects:

Regression models of COVID-19-related racial discrimination and anxiety symptoms among the full sample. by Ronna Bañada (19233063)

Subjects:

The raw data used in this study. by Yu Fu (16582)

Subjects:

Disease burden trends of leukemia and lymphoma analyzed by joinpoint regression analysis in mainland China. by Yu Fu (16582)

Subjects:

Disease burden trends of multiple myeloma and other hematological neoplasms analyzed by joinpoint regression analysis in mainland China. by Yu Fu (16582)

Subjects: